These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 30076764

  • 1. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling.
    Chang MT, Lee SP, Fang CY, Hsieh PL, Liao YW, Lu MY, Tsai LL, Yu CC, Liu CM.
    Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764
    [Abstract] [Full Text] [Related]

  • 2. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
    Huang JS, Yao CJ, Chuang SE, Yeh CT, Lee LM, Chen RM, Chao WJ, Whang-Peng J, Lai GM.
    BMC Cancer; 2016 Mar 24; 16():245. PubMed ID: 27012679
    [Abstract] [Full Text] [Related]

  • 3. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
    Huang KJ, Kuo CH, Chen SH, Lin CY, Lee YR.
    J Cell Mol Med; 2018 Mar 24; 22(3):1894-1908. PubMed ID: 29363886
    [Abstract] [Full Text] [Related]

  • 4. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G.
    J Cell Physiol; 2012 May 24; 227(5):2184-95. PubMed ID: 21792937
    [Abstract] [Full Text] [Related]

  • 5. 2-O-Methylmagnolol Induces Apoptosis and Inhibits IL-6/STAT3 Signaling in Oral Squamous Cell Carcinoma.
    Wang TH, Fang JY, Wu SJ, Liu YW, Chan CW, Chuang SY, Chen CY.
    Cell Physiol Biochem; 2018 May 24; 50(3):883-892. PubMed ID: 30355952
    [Abstract] [Full Text] [Related]

  • 6. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
    Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR.
    Clin Cancer Res; 2010 May 01; 16(9):2571-9. PubMed ID: 20388852
    [Abstract] [Full Text] [Related]

  • 7. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
    Ji N, Jiang L, Deng P, Xu H, Chen F, Liu J, Li J, Liao G, Zeng X, Lin Y, Feng M, Li L, Chen Q.
    J Oral Pathol Med; 2017 Mar 01; 46(3):201-207. PubMed ID: 27465776
    [Abstract] [Full Text] [Related]

  • 8. Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas.
    Peng CY, Yu CC, Huang CC, Liao YW, Hsieh PL, Chu PM, Yu CH, Lin SS.
    J Formos Med Assoc; 2022 Jan 01; 121(1 Pt 1):51-57. PubMed ID: 33551310
    [Abstract] [Full Text] [Related]

  • 9. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
    Zhou X, Ren Y, Liu A, Jin R, Jiang Q, Huang Y, Kong L, Wang X, Zhang L.
    Sci Rep; 2014 Dec 17; 4():7461. PubMed ID: 25514838
    [Abstract] [Full Text] [Related]

  • 10. Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit.
    Lin CS, Bamodu OA, Kuo KT, Huang CM, Liu SC, Wang CH, Tzeng YM, Chao TY, Yeh CT.
    Phytomedicine; 2018 Jul 15; 46():93-103. PubMed ID: 30097127
    [Abstract] [Full Text] [Related]

  • 11. Elimination of cancer stem-like cells and potentiation of temozolomide sensitivity by Honokiol in glioblastoma multiforme cells.
    Lai IC, Shih PH, Yao CJ, Yeh CT, Wang-Peng J, Lui TN, Chuang SE, Hu TS, Lai TY, Lai GM.
    PLoS One; 2015 Jul 15; 10(3):e0114830. PubMed ID: 25763821
    [Abstract] [Full Text] [Related]

  • 12. STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell.
    Bu LL, Zhao ZL, Liu JF, Ma SR, Huang CF, Liu B, Zhang WF, Sun ZJ.
    Oncotarget; 2015 Dec 08; 6(39):41944-58. PubMed ID: 26556875
    [Abstract] [Full Text] [Related]

  • 13. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
    Rodrigues MFSD, Miguita L, De Andrade NP, Heguedusch D, Rodini CO, Moyses RA, Toporcov TN, Gama RR, Tajara EE, Nunes FD.
    Int J Oncol; 2018 Dec 08; 53(6):2458-2472. PubMed ID: 30272273
    [Abstract] [Full Text] [Related]

  • 14. Multifunctional effects of honokiol as an anti-inflammatory and anti-cancer drug in human oral squamous cancer cells and xenograft.
    Cho JH, Jeon YJ, Park SM, Shin JC, Lee TH, Jung S, Park H, Ryu J, Chen H, Dong Z, Shim JH, Chae JI.
    Biomaterials; 2015 Dec 08; 53():274-84. PubMed ID: 25890726
    [Abstract] [Full Text] [Related]

  • 15. Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis.
    Wang X, Beitler JJ, Wang H, Lee MJ, Huang W, Koenig L, Nannapaneni S, Amin AR, Bonner M, Shin HJ, Chen ZG, Arbiser JL, Shin DM.
    PLoS One; 2014 Dec 08; 9(2):e86369. PubMed ID: 24586249
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H, Zang C, Emde A, Planas-Silva MD, Rosche M, Kühnl A, Schulz CO, Elstner E, Possinger K, Eucker J.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):43-51. PubMed ID: 18588872
    [Abstract] [Full Text] [Related]

  • 17. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J, Tsujii M, Kondo J, Hayashi Y, Kato M, Akasaka T, Inoue T, Shiraishi E, Inoue T, Hiyama S, Tsujii Y, Maekawa A, Kawai S, Fujinaga T, Araki M, Shinzaki S, Watabe K, Nishida T, Iijima H, Takehara T.
    Int J Oncol; 2015 Apr 04; 46(4):1551-9. PubMed ID: 25625841
    [Abstract] [Full Text] [Related]

  • 18. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
    Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y, Huang X, Shen L, Li Y, Cui Y, Song J, Shen B, Eliaz I, Huang R, Ying H, Guo H, Yan J.
    Oncotarget; 2015 Nov 10; 6(35):37335-48. PubMed ID: 26484567
    [Abstract] [Full Text] [Related]

  • 19. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC, Chen PN, Peng CY, Yu CH, Chou MY.
    Oncotarget; 2016 Apr 12; 7(15):20180-92. PubMed ID: 26933999
    [Abstract] [Full Text] [Related]

  • 20. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells.
    Ponnurangam S, Mammen JM, Ramalingam S, He Z, Zhang Y, Umar S, Subramaniam D, Anant S.
    Mol Cancer Ther; 2012 Apr 12; 11(4):963-72. PubMed ID: 22319203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.